loading
Overview
Strategic Report
Governance
Financial Statements
Company Information
Annual Report and Accounts for the year ended 30 June 2019
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide.
It is our mission to develop products sustainably to improve the welfare of animals globally.
Our products can be divided into four categories: Companion Animal Products (CAP), Food producing Animal Products (FAP), Equine, and Nutrition. All are targeted at providing veterinary professionals with solutions for their customers’ needs.
Species: Dogs and cats.
Key therapeutic sectors: Endocrinology, dermatology, analgesia and anaesthesia, antibiotics, cardiovascular and critical care.
Species: Poultry, pigs and an increasing presence in cattle.
Key therapeutic sectors: Water soluble antibiotics, poultry vaccines, locomotion (lameness) and pain management.
Species: Horses and ponies.
Key therapeutic sectors: Lameness and pain management.
Key therapeutic sectors: Supporting the wellbeing of cats and dogs with numerous therapeutic conditions, such as allergies, obesity, heart and kidney disease.
A key strategic priority for the Group is the delivery and strength of the pipeline. We currently have 56 projects in the product development process.
1
Feasiblity
12
2
Research
16
3
Development
19
4
Registration
9